These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33406870)

  • 21. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.
    Hamano K; Nakadaira I; Suzuki J; Gonai M
    Vasc Health Risk Manag; 2014; 10():585-9. PubMed ID: 25328404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes.
    Navarro Estrada JL; Rubinstein F; Bahit MC; Rolandi F; Perez de Arenaza D; Gabay JM; Alvarez J; Sarmiento R; Rojas Matas C; Sztejfman C; Tettamanzi A; de Miguel R; Guzman L;
    Am Heart J; 2006 May; 151(5):1093.e1-7. PubMed ID: 16644341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of N-terminal pro B-type natriuretic peptide for nonvalvular atrial fibrillation in acute ischemic stroke patients: A retrospective multicenter case-control study.
    Zhao J; Zhang Y; Yuan F; Song C; Jiang Y; Gao Q; Leng X; Jiang W
    J Neurol Sci; 2020 Jul; 414():116822. PubMed ID: 32278166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of Serum N-Terminal Pro-Brain Natriuretic Peptide Level over Heart Failure for Stroke Events and Deaths in Patients with Atrial Fibrillation.
    Kuronuma K; Okumura Y; Morikawa T; Yokoyama K; Matsumoto N; Tachibana E; Oiwa K; Matsumoto M; Kojima T; Haruta H; Nomoto K; Sonoda K; Arima K; Kogawa R; Takahashi F; Kotani T; Ohkubo K; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
    Int Heart J; 2020 May; 61(3):492-502. PubMed ID: 32418966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation.
    Vale NC; Campante Teles R; Madeira S; Brito J; Sousa Almeida M; Nolasco T; Abecasis J; Rodrigues G; Carmo J; Furstenau M; Ribeiras R; Neves JP; Mendes M
    Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):67-73. PubMed ID: 29317115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Terminal Pro-brain Natriuretic Peptide Is Associated With Hemorrhagic Transformation and Poor Outcomes in Patients With Stroke Treated With Intravenous Thrombolysis.
    Zhang KJ; Jin H; Xu R; Zhang P; Guo ZN; Yang Y
    Front Mol Neurosci; 2021; 14():758915. PubMed ID: 34880725
    [No Abstract]   [Full Text] [Related]  

  • 32. N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction.
    Ezekowitz JA; Théroux P; Chang W; Mahaffey KW; Granger CB; Weaver WD; Hochman JS; Armstrong PW
    Can J Cardiol; 2006 Apr; 22(5):393-7. PubMed ID: 16639474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does N-terminal Pro-brain Type Natriuretic Peptide Predict Cardiac Complications After Hip Fracture Surgery?
    Ushirozako H; Ohishi T; Fujita T; Suzuki D; Yamamoto K; Banno T; Takase H; Matsuyama Y
    Clin Orthop Relat Res; 2017 Jun; 475(6):1730-1736. PubMed ID: 28101755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-Terminal Pro-B-Type Natriuretic Peptide Is Not a Significant Predictor of Stroke Incidence After 5 Years　- The Ohasama Study.
    Satoh M; Murakami T; Asayama K; Hirose T; Kikuya M; Inoue R; Tsubota-Utsugi M; Murakami K; Matsuda A; Hara A; Obara T; Kawasaki R; Nomura K; Metoki H; Node K; Imai Y; Ohkubo T
    Circ J; 2018 Jul; 82(8):2055-2062. PubMed ID: 29887544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of C-reactive protein as an inflammatory and N-terminal probrain natriuretic peptide as a neurohumoral marker in acute heart failure (from the Korean Heart Failure registry).
    Park JJ; Choi DJ; Yoon CH; Oh IY; Jeon ES; Kim JJ; Cho MC; Chae SC; Ryu KH; Yoo BS; Kang SM; Oh BH;
    Am J Cardiol; 2014 Feb; 113(3):511-7. PubMed ID: 24315115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
    Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A
    Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined effect of serum N-terminal pro-brain natriuretic peptide and galectin-3 on prognosis 1 year after ischemic stroke.
    Liu Y; Guo D; Wang A; Yang J; Zhu Z; Xu T; Zhong C; Peng H; Chen J; Zhou Y; Zhang Y; He J
    Clin Chim Acta; 2020 Dec; 511():33-39. PubMed ID: 32986993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke.
    Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B
    Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy.
    Sheng X; Yang J; Yu G; Fei Y; Bao H; Yin J; Huang W; Tian Z; Wang N; Ronco C
    Blood Purif; 2019; 48(3):262-271. PubMed ID: 31311006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.